Primary |
Surgery |
42.9% |
Preoperative Care |
10.7% |
Product Used For Unknown Indication |
8.9% |
Anaesthesia |
7.1% |
Drug Use For Unknown Indication |
7.1% |
Arrhythmia |
5.4% |
Hypertension |
5.4% |
Antibiotic Prophylaxis |
1.8% |
Cataract Operation |
1.8% |
Intraoperative Care |
1.8% |
Pancreatitis Necrotising |
1.8% |
Prophylaxis |
1.8% |
Therapeutic Skin Care Topical |
1.8% |
Wound Treatment |
1.8% |
|
Wrong Technique In Drug Usage Process |
21.2% |
Postoperative Infection |
12.1% |
Punctate Keratitis |
9.1% |
Endophthalmitis |
6.1% |
Skin Irritation |
6.1% |
Burns Second Degree |
3.0% |
Consciousness Fluctuating |
3.0% |
Dermatitis |
3.0% |
Drug Hypersensitivity |
3.0% |
Hypertension |
3.0% |
Hyperthyroidism |
3.0% |
Impaired Healing |
3.0% |
Mental Status Changes |
3.0% |
Multi-organ Failure |
3.0% |
Pneumonia Aspiration |
3.0% |
Post Procedural Drainage |
3.0% |
Rash |
3.0% |
Swelling |
3.0% |
Throat Irritation |
3.0% |
Thyroid Disorder |
3.0% |
|
Secondary |
Drug Use For Unknown Indication |
24.4% |
Intraocular Lens Implant |
22.1% |
Premedication |
13.7% |
Preoperative Care |
8.6% |
Product Used For Unknown Indication |
7.0% |
Anaesthesia |
5.9% |
Prophylaxis |
3.4% |
Cataract Operation |
1.9% |
Infection Prophylaxis |
1.9% |
Local Anaesthesia |
1.7% |
Postoperative Wound Infection |
1.5% |
Age-related Macular Degeneration |
1.1% |
Postoperative Care |
1.1% |
Type 2 Diabetes Mellitus |
1.1% |
Macular Degeneration |
1.0% |
Colitis Ulcerative |
0.8% |
Intraocular Pressure Increased |
0.8% |
Antibiotic Prophylaxis |
0.6% |
Caesarean Section |
0.6% |
Skin Lesion |
0.6% |
|
Renal Failure Acute |
34.2% |
Toxic Anterior Segment Syndrome |
18.5% |
Drug Hypersensitivity |
6.5% |
Medication Error |
6.5% |
Endophthalmitis |
3.8% |
Thrombocytopenia |
3.8% |
Toxic Skin Eruption |
3.8% |
Urticaria |
3.8% |
Angioedema |
2.7% |
Anaphylactic Shock |
2.2% |
Respiratory Disorder |
2.2% |
Ulcerative Keratitis |
2.2% |
Post Procedural Complication |
1.6% |
Vomiting |
1.6% |
Laryngeal Oedema |
1.1% |
Post Procedural Infection |
1.1% |
Pruritus |
1.1% |
Punctate Keratitis |
1.1% |
Rash |
1.1% |
Renal Tubular Necrosis |
1.1% |
|
Concomitant |
Drug Use For Unknown Indication |
20.2% |
Product Used For Unknown Indication |
10.3% |
Prophylaxis |
6.8% |
Cataract Operation |
6.7% |
Diabetes Mellitus |
6.7% |
Infection |
5.2% |
Metastatic Renal Cell Carcinoma |
5.0% |
Insomnia |
4.2% |
Pyrexia |
3.8% |
Retinal Haemorrhage |
3.8% |
Muscle Spasms |
3.4% |
Vomiting |
3.4% |
Hypertension |
3.3% |
Colonoscopy |
2.6% |
Facet Joint Block |
2.6% |
Anaesthesia |
2.5% |
Gastritis Prophylaxis |
2.5% |
Infection Prophylaxis |
2.4% |
Diarrhoea |
2.3% |
Premedication |
2.3% |
|
Endophthalmitis |
15.5% |
Sepsis |
13.4% |
Renal Failure Acute |
12.8% |
Toxic Anterior Segment Syndrome |
10.7% |
Weight Decreased |
10.7% |
Vitreous Haemorrhage |
5.9% |
Visual Acuity Reduced |
4.3% |
Drug Ineffective |
3.7% |
Retinal Detachment |
2.7% |
Vitritis |
2.7% |
Rash |
2.1% |
Varices Oesophageal |
2.1% |
Vomiting |
2.1% |
Acute Myocardial Infarction |
1.6% |
Corneal Oedema |
1.6% |
Dyspnoea |
1.6% |
Nausea |
1.6% |
Pneumonia |
1.6% |
Retinal Haemorrhage |
1.6% |
Streptococcal Infection |
1.6% |
|